Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1996-09-12
1999-02-23
Saucier, Sandra E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514 21, 514 34, 540 72, 536 5, 424520, A01N 4500, A01N 4304, A61K 3800, A61K 3512
Patent
active
058744231
ABSTRACT:
A human cataractous lens nuclei methanolic extract characterized in that it comprises substances having a molecular weight lower than 3000 daltons, inhibiting ATP hydrolysis by Na.sup.+,K.sup.+ -ATPase having affinity to the ouabain binding site on the enzyme and cross-reacting with an antibody directed against digoxin. Compounds of the general formula are disclosed: ##STR1## or of the general formula: ##STR2## in which R is hydrogen, an amino acid, a di- or tripeptide or a mono-, di- or trisaccharide. Pharmaceutical preparations and methods of using the compounds are also disclosed.
REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3839153 (1974-10-01), Schuurs et al.
patent: 3850578 (1974-11-01), McConnell
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3879262 (1975-04-01), Schuurs et al.
patent: 3901654 (1975-08-01), Gross
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3984533 (1976-10-01), Uzgiris
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4034074 (1977-07-01), Miles
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4380624 (1983-04-01), Wiesner et al.
patent: 4780314 (1988-10-01), Graves
patent: 4879219 (1989-11-01), Wands et al.
patent: 5011771 (1991-04-01), Bellet et al.
patent: 5281521 (1994-01-01), Trojanowski et al.
Gupta et al., "Cellular Basis for the Species Differences in Sensitivity to ardiac Gycosides (Digitalis)", J. Cell. Physiol. 127(2) : 197-206 (1986).
Clarkson and de Wardener, "Observations on a low molecular weight natriuretic and Na-K-ATpase inhibitory material in urine" Clin. and Exper.--Theory and Practice, A7(5&6), pp. 673-683 (1985).
Akagawa et al., "Partial purification and properties of the inhibitors of Na, K-ATPase and Ouabain-binding . . . " J. Neurochem. 42:775-780 (1984).
Bidard et al., "A search for an `ouabain-like` substance from the electric organ of electrophorus electricus . . . " Biochim. Biphys. Acta 769:245-252 (1984).
Cloix et al., "An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies" Can. J. Physiol. Pharmacol., 65:1522-1527 (1987).
Cotlier, "The Lens" in Adler's Physiology of the Eye, pp. 277-303, ed. R.A. Moses, The C.V. Mosby Company, St. Louis (1981).
Dasgupta et al., "Two novel endogenous digoxin-like immunoreactive substances isolated from human plasma ultrafiltrate" Biochem. Biophys. Res. Commun., 148:623-628 (1987).
De Pover et al., "Water versus acetone-HC1 extraction of digitalis-like factor from guinea-pig heart" Biochem. Pharmacol., 31:267-271 (1982).
De Wardener and Clarkson, "Concept of natriuretic hormone" Physiological Reviews, 65:658-759 (1985).
Fagoo et al., "Evidence that mammalian lignans show endogenous digitalis-like activities" Biochem. Biophys. Res. Commun. 134:1064-1070 (1986).
Flier et al., "Widespread occurrence in frogs and toads of skin compounds interacting with the Ouabain . . . " Science, 208:503-505 (1980).
Fukui et al., "A possible cataractogenic factor in the nakano mouse lens" Exp. Eye Res., 26:1-9 (1978).
Goto et al., "Isolation of urinary digitalis-like factor indistinguishable from digoxin" Biochem. Biophys. Res. Commun., 173:1093-1101 (1990).
Gruber et al., "Endogenous digitalis-like substance in plasma of volume-expanded dogs" Nature, 237:743-745 (1980).
Haber and Haupert, "The search for a hypothalamic Na , K ATPase Inhibitor" Hypertension, 9:315-324 (1987).
Halperin et al., "Ouabain-like activity in human cerebrospinal fluid" Proc. Natl. Acad. Sci. USA, 80:6101-6104 (1983).
Hamlyn et al., "Identification and characterization of a ouabain-like compound from human plasma" Proc. Natl. Acad. Sci. USA, 88:6257-6263 (1991).
Haupert and Sancho, "Sodium transport inhibitor from bovine hypothalamus" Proc. Natl. Acad. Sci. USA, 76:4658-4660 (1979).
Itawa and Kinoshita, "Mechanism of development of hereditary cataract in mice" Invest. Ophthalmol., 10:504-512 (1971).
Kamei and Sakai, "Characterization of peptide inducing cataractogenesis in lens of hereditary cataractous rat (ICR/f Rat)" Abstract only.
Kelly et al., "Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids" J. Biol. Chem., 261:11704-11711 (1986).
Kramer et al., "Antinatriferic activity in human plasma following acute and chronic salt-loading" Kidney International, 12:214-219 (1977).
Lichtstein et al., "Identification of digitalis-like compounds in human cataractous lenses" European Journal of Biochemistry, vol. 216, pp. 261-268 (1993).
Lichtstein et al., "Effect of salt acclimation on digitalis-like compounds in the toad" Biochem. Biophys. Acta., 1073:65-68 (1991a).
Lichtstein et al., "Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating . . . " J. Endocrinol., 128:71-78 (1991b).
Lichtstein et al., "Identification of a ouabain-like compound in toad skin and plasma as a bufodienolide derivative" Life Sciences, 38:1261-1270 (1986).
Lichtstein et al., "Evidence for the presence of `ouabainlike` compound in human cerebrospinal fluid" Brain Res., 325:13-19 (1985).
Lichtstein and Samuelov, "Endogenous `ouabain like` activity in rat brain" Biochem. Biophys. Res. Com., 96:1518-1523 (1980).
Lowry et al., "Protein measurement with the folin phenol reagent" J. Biol. Chem., 36:265-275 (1951).
Meyer and Kinde, "Collection of toad venoms and chemistry of the toad venom steroids" in Venomous Animals and Their Venoms, vol. 2, pp. 521-522, eds. W. Bucherl and E. Buckley, NY Academic Press (1971).
Moreth et al., "Blood pressure in essential hypertension correlates with the concentration of a circulating inhibitor of the sodium pump" Klinische Wochenschrift, 64:239-244 (1986).
Nakano et al., "Study on the subretinal fluid report 1. refracto-metric and paper-electrophoretic study . . . " Jap. J. Ophthalmol., 14:196 (1960).
Ng et al., "Ascorbia acid: an endogenous inhibitor of isolated . . . " Biochem. Pharmacol., 34:2525-2530 (1985).
Russell et al., "Properties of a Na-K ATPase inhibitor in cultured lens epithelial cells" in Vision Research, vol. 21, pp. 37-39 (1981).
Sen and Pffifer, "Characterization of partially purified (Na+ and K+) -ATPase from porcine lens" Biochim. Biophys. Acta., 693:33-34 (1982).
Tamura et al., "Isolation and characterization of a specific endogenous Na . . . " Biochemistry, 27:4244-4253 (1988).
Tamura et al., "Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na . . . " Biochemistry, 26:2797-2806 (1987).
Tamura et al., "Identification of linoleic and oleic acids as endogenous Na . . . " J. Biol. Chem., 260:9672-9677 (1985).
Van Winkle et al., "The nature of the transport ATPase-digitalis complex: III. Rapid binding studies . . . " in Archives of Biochemistry and Biophysics, vol. 151, No. 1, pp. 85-92 (1972).
Vasdev et al., "Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults" Res. Commun. Chem. Path. and Pharmacol., 49:387-399 (1985).
Wechter and Benaksas, "Natriuretic hormones" Prog. Drug. Res., 34:231-260 (1990).
Deutsch Joseph
Gati Irit
Lichtstein David
Saucier Sandra E.
Yissum Research Development Co. of the Hebrew University of Jeru
LandOfFree
Digitalis-like compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Digitalis-like compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Digitalis-like compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307098